Gao Yan, PhD¹, Liling Zhang^2*, Wenyu Li^3*, Xu Wei, MD, PhD⁴, Ru Feng^5*, Xue-Ping Li^6*, Yu Chen^7*, Huijing Wu, MD^8*, Xiaoxiao Wang^9*, Bing Bai^9* and Huiqiang Huang, MD, PhD¹⁰

¹Sun Yat-Sen University Cancer Center, Guangzhou, China
²Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Sc, Wuhan, CHN
³Guangdong Provincial People's Hospital, Guangzhou, China
⁴Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing City, Jiangsu Province, China
⁵Nanfang Hospital, Southern Medical University, Guangzhou, China
⁶Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
⁷Department of pathology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
⁸Hubei Cancer Hospital, Wuhan, China
⁹Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
¹⁰Department of Medical Oncology, Sun Yat-Sen Univ. Cancer Ctr., Guangzhou, Guangdong, China

Mingzhi Zhang, PhD, MD^1*, Lei Zhang, PhD, MD^1*, Xin Li, MD^1*, Ling Li^2*, Xinhua Wang, PhD, MD^1*, Xiaorui Fu, PhD, MD^3*, Zhenchang Sun, PhD, MD^1*, Yu Chang, MD^1*, Xudong Zhang^1*, Hui Yu, PhD, MD^1*, Feifei Nan, PhD, MD^1*, Zhiyuan Zhou, PhD, MD^1*, Xiyang Liu, MD^1*, Xiaolong Wu^1*, Liqun Zou, MD, PhD^4*, Hui Zhou, Ph.D.⁵ and Hongwei Xue, PhD^6*

¹Department of Oncology, The First Affiliated Hospital of Zhengzhou University&Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China
²Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
³Department of Oncology, The First Affiliated Hospital of Zhengzhou University&Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
⁴West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
⁵Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
⁶The first affliated hospital of Qingdao University, Qingdao, CHN

Alexander Pichler^1*, Christoph Kornauth, MD^2*, Ines Garces De Los Fayos Alonso, MSc^3*, Lukas Kazianka^4*, Arne Zibat^5*, Luca Mologni, PhD^6*, Halima Alachram^5*, Tea Pemovska^7*, Gerwin Heller, PhD^4*, Richard Greil, MD⁸, Lukas Kenner^4*, Ulrich Jaeger, MD^1* and Philipp Bernhard Staber, MD, PhD¹

¹Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
²MLL Munich Leukemia Laboratory, Munich, Germany
³University of Veterinary Medicine Vienna, Vienna, AE, AUT
⁴Medical University of Vienna, Vienna, AUT
⁵Institute of Human Genetics, Georg August University of Goettingen, Goettingen, Germany
⁶Department of Medicine and Surgery, University Milano-Bicocca, Monza, Italy
⁷Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
⁸Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria

Christopher Dittus, DO¹, Matthew Weinstock, MD^2*, Jeffrey A. Barnes, MD, PhD³, Jose Sandoval-Sus, MD⁴, Natalie S. Grover, MD¹, Anne Beaven, MD¹, Xianming Tan, PhD^1*, Areej El-Jawahri, MD⁵, Shayna R Sarosiek⁶ and John Mark Sloan, MD⁷

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²Beth Israel Deaconess Medical Center, Boston, MA
³Massachusetts General Hosp. Cancer Ctr., Boston, MA
⁴H Lee Moffitt Cancer Center at Memorial Cancer Institute, Ft Lauderdale, FL
⁵Massachusetts General Hospital, Allston, MA
⁶Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
⁷Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA

Nathalie A. Johnson, MD, PhD,¹, David Lavie^2*, Peter Borchmann³, Gareth P. Gregory⁴, Alex F. Herrera, MD⁵, Leonard Minuk, MD, FRCPC⁶, Vladan Vucinic, M.D.^7*, Philippe Armand, MD, PhD⁸, Abraham Avigdor, MD⁹, Robin Gasiorowski, MA, FRACP, FRCPA, MBBS¹⁰, Yair Herishanu^11*, Colm Keane, MD¹², John Kuruvilla, MD, FRCPC¹³, Rachel Marceau West^14*, Pallavi Pillai, MD¹⁴, Patricia Marinello, PharmD¹⁴ and John Timmerman, MD¹⁵

¹Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
²Hadassah Medical Center, Jerusalem, Israel
³University Hospital Cologne, Cologne, Germany
⁴School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia
⁵City of Hope, Duarte, CA
⁶CancerCare Manitoba and University of Manitoba, Winnipeg, MB, Canada
⁷Leipzig University Medical Center, Clinic and Policlinic for Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany
⁸Dana-Farber Cancer Institute, Boston, MA
⁹Sheba Medical Center–Tel HaShomer, Ramat Gan, Israel
¹⁰Concord Hospital, University of Sydney, Concord, NSW, Australia
¹¹Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel
¹²Princess Alexandra Hospital, Brisbane, QLD, Australia
¹³Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁴Merck & Co., Inc., Rahway, NJ
¹⁵UCLA Medical Center, Los Angeles, CA

Rong Tao, MD^1*, Chuanxu Liu, MD^1*, Wenhao Zhang, MD^1*, Yang Zhu, MD^2* and Yujie Ma, MD^2*

¹Department of Lymphoma, Fudan University, Shanghai Cancer Center, Shanghai, China
²Department of Hematology, Xinhua Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China

Eugenio Fardella, MD^1*, Giada Zanirato^2*, Martina Magni^2*, Nicole Caldarelli^3*, Annalisa Chiappella, MD⁴, Anna Dodero^2*, Silva Ljevar^5*, Lorella Orsucci, MD^6*, Alessandro Re, MD^7*, Sara Usai, MD^8*, Vittorio Stefoni^9*, Claudia Castellino, MD^10*, Francesca Gaia Rossi^11*, Antonio Pinto, MD^12*, Cristiana Carniti^13* and Paolo Corradini, MD¹⁴

¹Fondazione IRCCS Istituto Nazionale dei Tumori, Hematology, University of Milan, Milan, Italy
²Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
³Fondazione IRCCS Istituto Nazionale Tumori, Hematology, University of Milan, Milano, Italy
⁴Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milano, Italy
⁵Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy, Milan, ITA
⁶Hematology Division, A.O.U Città della Salute e della Scienza, Ospedale S. Giovanni Battista Molinette, Torino, Italy
⁷UC Hematology, ASST Spedali Civili di Brescia, Brescia BS, Italy
⁸Ospedale Oncologico Armando Businco, Cagliari, ITA
⁹Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
¹⁰SC Ematolgoa, Ospedale Santa Croce e Carle, Cuneo, Italy
¹¹Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, ITA
¹²Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
¹³Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
¹⁴Hematology Division, University of Milan. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Kaiyang Ding^1*, Jie Ma, MD^2*, Xiaohui Zhang, MD^3*, Chunling Wang, MD^4*, Huang Hongming^5*, Lixia Sheng^6*, Hailing Liu^6*, Lei Cao^7*, Wei Wu^8*, Jianyong Li, MD⁸ and Lei Fan, MD^8*

¹Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
²Department of Hematology, The first affiliated hospital of Zhengzhou University, Henan, China
³The Second Affiliated Hospital of Soochow University, Suzhou, China
⁴Department of Hematology, Huai'an First People's Hospital, Huai'an, China
⁵The Affiliated Hospital of Nantong University,, Jiangsu, China
⁶The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⁷Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⁸Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Matthew G. Mei, MD¹, Lu Chen, PhD^2*, Sandrine Puverel, PhD^3*, Elizabeth Lihua Elizabeth Budde, MD, PhD⁴, Swetha Kambhampati, MD³, Shari Daniels^1*, Bev Dunning^1*, Melissa Banez, CCR^5*, Larry W. Kwak³ and Alex F. Herrera, MD⁶

¹City of Hope National Medical Center, Duarte, CA
²Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
³Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
⁴Department of Hematology and HCT, City of Hope, Duarte, CA
⁵Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
⁶City of Hope, Duarte, CA

Seda S. Tolu, MD¹, Caitlin Gribbin, MD^2*, Madhav R Seshadri, MD³, Zhengming Chen, PhD^4*, Evelyn Orlando, MD⁵, Justin Grenet, MD, MPhil⁶, Rajbir Toor^6*, Alexander Sanjurjo⁷, Adrienne A. Phillips, MD, MPH², Tsiporah B. Shore, MD⁸, Peter Martin, MD⁹, John P. Leonard¹⁰, Barbara Pro, MD¹¹, Jennifer E. Amengual, MD¹² and Jia Ruan, MD, PhD¹³

¹Division of Hematology and Oncology, Columbia University Irving Medical Center, New York City, NY
²Weill Cornell, New York, NY
³University of California San Francisco, San Francisco, CA
⁴Weill Cornell medicine, New York, NY
⁵Columbia University Medical Center, New York, NY
⁶Weill Cornell, New York
⁷Columbia University Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York
⁸Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY
⁹Weill Cornell Medicine, New York
¹⁰Weill Cornell Medicine, New York, NY
¹¹Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
¹²Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
¹³Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY

Lianna J. Marks, MD¹, Kathleen McCarten, MD, FACR^2*, Qinglin Pei, PhD^3*, Yue Wu^4*, Kara M. Kelly, MD⁵, Cindy Schwartz, MD⁶, Suzanne Wolden^7*, Debra L. Friedman, MD, MS⁸, Sharon M. Castellino, MD, MSc⁹ and Burton Appel, MD, MBA¹⁰

¹Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Palo Alto, CA
²Rhode Island Hospital, Providence, RI
³COG Data Center, University of Florida College of Public Health & Health Professions and College, Gainesville, FL
⁴COG Data Center, University of Florida, Gainesville, FL
⁵Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁶Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
⁷Memorial Sloan Kettering Cancer Center, New York, NY
⁸Vanderbilt-Ingram Cancer Center, Nashville, TN
⁹Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
¹⁰Hackensack Univ. Med. Ctr., Hackensack, NJ

Lisa Giulino Roth, MD¹, Frank Keller, MD^2*, Mario Melgar Toledo^3*, Sharon M. Castellino, MD, MSc², Christopher J. Forlenza, MD⁴, Maitane Andión Catalan^5*, Julie Krystal, MD^6*, Adam Lamble, MD^7*, Aarati V. Rao, MD, MBBS⁸, Fabio Molina Morales^9*, Stacy Cooper, MD¹⁰, Flavio Luisi^11*, Oscar Gonzalez Llano^12*, Karla Alejandra Lopez^13*, Christine Mauz-Koerholz, MD^14,15, Bradford Hoppe, MD, MPH^16*, Juan Shen^17*, Pallavi Pillai, MD¹⁷, Patricia Marinello, PharmD¹⁷ and Kara M. Kelly, MD¹⁸

¹Weill Cornell Medicine, New York
²Children's Healthcare of Atlanta at Egleston, Atlanta, GA
³Unidad Nacional de Oncologia Pediatrica, Guatemala City, Guatemala
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Hospital Infantil Universitario Nino Jesus, Madrid, Spain
⁶Cohen Children's Medical Center of New York, Queens, NY
⁷Seattle Childrens Hospital, Seattle, WA
⁸Kaiser Permanente Roseville Medical Center, Roseville, CA
⁹Oncomédica S.A.S, Monteria, Colombia
¹⁰Johns Hopkins University, Baltimore, MD
¹¹Instituto de Oncologia Pediatrica - GRAACC – Unifesp, Sao Paulo, Brazil
¹²Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Mexico, Monterrey, Mexico
¹³Oncomedica, Guatemala City, Guatemala
¹⁴Justus-Liebig University of Giessen, Giessen, Germany
¹⁵Medical Faculty of the Martin-Luther-University of Halle-Wittenberg, Halle, Germany
¹⁶Mayo Clinic, Jacksonville, FL
¹⁷Merck & Co., Inc., Rahway, NJ
¹⁸Roswell Park Comprehensive Cancer Center, Buffalo, NY

Bong-Seog Kim, MD¹, Seok Jin Kim, MD, PhD², Dok Hyun Yoon, MD, PhD^3*, Jin Seok Kim, MD, PhD^4*, Tae Min Kim, MD, PhD^5*, Eunyoung Lee^6*, Jeong-Ok Lee, MD⁷, Deok-Hwan Yang, MD, PhD^8* and Won-Sik Lee^9*

¹Boryung, Seoul, South Korea
²Samsung Med. Ctr., Seoul, KOR
³Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
⁵Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶National Cancer Center, Seoul, Korea, Republic of (South)
⁷Department of Internal Medicine, Seoul National Univ. Bundang Hospital, Seongnam-Si, None, KOR
⁸Hematology-Oncology, Chonnam National University Hwasun Hospital, Hawsun, Jeollanam-Do, Korea, Republic of (South)
⁹Inje Univ. Busan Baik-Hospital, Busan, KOR

Brittney Munayirji^1*, Niloufer Khan, MD², Patricia Myskowski, MD^1*, Shamir Geller, MD^1*, Sarah Noor, MD^3*, Meenal Kapoor Kheterpal, MD^4*, Theresa Davey, MMSc, PA-C^1*, Helen Hancock, ANP^1*, Leslie Perez, RN^1*, Tayler Miller, RN^1*, Jamila Brutus, NP^1*, Nivetha Ganesan^1*, Tiffany Chang, MS^1*, Gianna Mangiaracina^1*, Richa Patel^1*, Natasha Galasso^1*, Ellie Casper^1*, Paola Ghione, MD, MSEpi¹, Robert Stuver, MD¹, Zachary D. Epstein-Peterson, MD⁵, Melissa Pulitzer, MD^1*, Michael S. Khodadoust, MD^6*, Youn H. Kim, MD⁶, Steven M. Horwitz, MD¹ and Alison Moskowitz, MD¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Northwell Health, New Hyde Park, NY
⁴Duke Cancer Center, Durham, NC
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Departments of Dermatology and Medicine - Oncology, Stanford University School of Medicine, Stanford, CA

Min Jung Koh, MS¹, Leora Boussi, MD^2*, Jessy Xinyi Han, BS^3*, Luke Peng^4*, Mark N Sorial, PharmD, RPh^5*, Ijeoma Julie Eche-Ugwu, PhD^6,7*, Eliana Miranda, MEd, PhD^8*, Carlos Chiattone, MD, PhD^9*, Robert Stuver, MD¹⁰, Steven M. Horwitz, MD¹¹, Maria J. Fernandez Turizo, MD¹², Sean McCabe, BS^13*, Mwanasha Hamuza Merrill, MD¹⁴, Eric Jacobsen, MD¹⁵, Jin Seok Kim, MD, PhD^16*, Yu Ri Kim, MD¹⁷, Jae Yong Cho, MD, PhD^18*, Thomas Eipe, PharmD^19*, Tanuja Shet, MBBS, MD, DPB, DNB, DTM^20*, Hasmukh Jain, MD, DM^21*, Manju Sengar, MD, DM²¹, Shambhavi Singh, MD, PhD^22*, Judith Gabler, MD^13*, Min Ji Koh, BA^22*, Carrie Van Der Weyden, MBBS (Hons), FRACP, FRCPA^23*, Miles Prince, MBBS (Hons), MD, FRACP, FRCPA, AFRCMA, MACD, FAHMS²⁴, Ramzi Hamouche, MD²⁵, Tinatin Muradashvili, MD^25*, Francine M. Foss, MD²⁶, Marianna Gentilini, MD^27*, Beatrice Casadei, MD, PhD^28*, Pier Luigi Zinzani, MD, PhD²⁸, Takeshi Okatani, MD^29*, Noriaki Yoshida, MD, PhD³⁰, Sang Eun Yoon, MD^31*, Won Seog Kim, MD, PhD^32*, Girisha Panchoo, MBBS^33*, Zainab Mohamed, MBChB, MMed^34*, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD³⁵, Jackielyn Cuenca Alturas, BA^36*, Mubarak Al Mansour, MD^37*, Josie Ford, BS^13*, Martina Manni, PhD^38*, Massimo Federico, MD³⁹, Owen A. O'Connor, MD, PhD^40*, Maria Elena Cabrera, MD^41*, Changyu Shen, PhD^42*, Enrica Marchi, MD, PhD⁴³, Devavrat Shah, PhD^3* and Salvia Jain, MD^44,45,46

¹Georgetown University School of Medicine, Washington, DC
²Medical Oncology & Hematology, Memorial Sloan Kettering Cancer Center, New York, NY
³Massachusetts Institute of Technology, Cambridge, MA
⁴College of Science, Northeastern University, Boston, MA
⁵Department of Pharmacy, Massachusetts General Hospital Cancer Center, Boston, MA
⁶Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana Farber Cancer Institute, Boston, MA
⁷Beth Israel Deaconess Medical Center, Boston, MA
⁸University of Campinas (UNICAMP), Hematology and Hemotherapy Center (Hemocentro), Sao Paulo, Brazil
⁹University of Campinas (UNICAMP), Hematology and Hemotherapy Center (Hemocentro), San Paulo, Brazil
¹⁰Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
¹³Massachusetts General Hospital Cancer Center, Boston, MA
¹⁴Dana Farber Cancer Institute, Boston, MA
¹⁵Dana-Farber Cancer Institute, Boston, MA
¹⁶Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
¹⁷Division of Hematology, Department of Internal Medicine, Hematology, Gangnam Severance Hospital, Seoul, South Korea
¹⁸Department of Medicine, Gangnam Severance Hospital, Yonsei University School of Medicine, Seoul, Korea, Republic of (South)
¹⁹Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, India
²⁰Department of Pathology, Tata Memorial Centre, Mumbai, India
²¹Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
²²Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA
²³Department of Hematology, Peter MacCallum Cancer Center, Melbourne, VIC, AUS
²⁴Peter MacCallum Cancer Inst., East Melbourne, VIC, AUS
²⁵Department of Hematology, Yale Cancer Center, New Haven, CT
²⁶Yale University School of Medicine, New Haven, CT
²⁷Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
²⁸Hematology, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
²⁹Hiroshima Red Cross & A-Bomb Survivors Hospital, Hiroshima City, JPN
³⁰Radiation Effects Research Foundation, Hiroshima-Shi, JPN
³¹Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
³²Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
³³University of Cape Town and Groote Schuur Hospital, Cape town, South Africa
³⁴University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
³⁵Department of Medicine, Division of Clinical Haematology, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
³⁶Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia
³⁷Department of Medicine, King Abdulaziz Medical City, Jeddah, SAU
³⁸Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, ITA
³⁹University of Modena and Reggio Emilia, Modena, MO, ITA
⁴⁰University of Virginia, Charlottesville, VA
⁴¹Hospital Del Salvador, Santiago, Chile
⁴²Biogen, Cambridge, MA
⁴³Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA
⁴⁴Broad Institute of Harvard and MIT, Boston
⁴⁵Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
⁴⁶Harvard Medical School, Boston

Michi M Shinohara, MD^1*, Youn H. Kim, MD², Kevin Molloy, RCSI PhD^3*, Pietro Quaglino, MD^4*, Julia Scarisbrick, MD FRCP^5*, Susan R. Thornton^6*, Kerry Sandilands^7*, Jen E Liu, PhD^8*, Annabel Nixon, PhD^9*, Angela Williams, PhD^10* and Pablo L. Ortiz-Romero, MD, PhD^11*

¹Division of Dermatology, University of Washington, Seattle, WA
²Departments of Dermatology and Medicine - Oncology, Stanford University School of Medicine, Stanford, CA
³Tallaght University Hospital, Dublin, Ireland
⁴Dermatologic Clinic, Dept Medical Sciences, University of Turin, Torino, ITA
⁵University Hospital Birmingham, Birmingham, United Arab Emirates
⁶Cutaneous Lymphoma Foundation, Warren, MI
⁷Kyowa Kirin International, Galashiels, United Kingdom
⁸Chilli Consultancy Ltd, Salisbury, United Kingdom
⁹Chilli Consultancy Ltd, Salisbury, ENG, United Kingdom
¹⁰Kyowa Kirin International, Marlow, United Kingdom
¹¹Hospital 12 de Octubre Medical School, University Complutense, Madrid, Spain

Terrence Chew, MD¹, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, PhD^2*, Vinod Ganju, MBBS, FRACP^3*, Steven Grant, M.D.^4*, Said Sebti^5* and H. Miles Prince, MD⁶

¹Prescient Therapeutics, Limited, Allyn, WA
²Epworth HealthCare, Melbourne, VIC, Australia
³Peninsula Oncology Centre Consulting Suite, Frankston, VIC, AUS
⁴Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
⁵Moffitt Cancer Center, Tampa, FL
⁶Peter MacCallum Cancer Inst., East Melbourne, VIC, AUS

Anna Maria Sureda Balari, MD, PhD¹, Herve Ghesquieres, MD, PhD^2*, Franck Morschhauser, phd³, Pim Mutsaers, MD^4*, Enrique M Ocio, MD, PhD⁵, Tomas Janik^6*, Nick Manamley^6*, Kasia Hilgier, MD^6* and Pier Luigi Zinzani, MD, PhD⁷

¹Clinical Hematology, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain
²Hematology Department, Hopital Lyon Sud - HCL, Lyon, France
³Hôpital Claude Huriez, Lille, France
⁴Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁵Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain
⁶Mundipharma Research Ltd, Cambridge, United Kingdom
⁷Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy

Hidehiro Itonaga, MD, PhD¹, Takuya Fukushima, MD, PhD², Koji Kato, M.D., Ph.D.^3*, Nobuaki Nakano, M.D.^4*, Takeharu Kato, M.D., Ph.D.^5*, Takashi Tanaka, MD^6*, Tetsuya Eto, MD, PhD^7*, Yasuo Mori, M.D., Ph.D.^8*, Toshiro Kawakita, MD, PhD^9*, Naoyuki Uchida, MD, PhD¹⁰, Yasushi Sawayama, M.D., Ph.D.^11*, Takahiro Fukuda, MD, PhD^6*, Yoshinobu Kanda^12*, Yoshiko Atsuta, MD, PhD^13*, Makoto Yoshimitsu, MD, PhD¹⁴ and Shigeo Fuji, MD, PhD^15*

¹Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki city, NSK, Japan
²Laboratory of Hematoimmunology, University of the Ryukyus, Nishihara-Cho, Okinawa, JPN
³Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
⁴Department of Hematology, Imamura General Hospital, Kagoshima, Japan
⁵Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
⁶Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
⁷Department of Hematology, Hamanomachi Hospital, Fukuoka, JPN
⁸Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, JPN
⁹Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
¹⁰Department of Hematology, Toranomon Hospital, Tokyo, Japan
¹¹Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
¹²Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
¹³Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
¹⁴Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan
¹⁵Osaka International Cancer Center Institute, Osaka, Japan

Christina Poh, MD^1,2, Xinyi Fan^1*, Jenna M Voutsinas, MPH^1*, Qian Wu^1*, Michi M Shinohara, MD^1,3*, Phuong T Vo, MD^1,2, Mazyar Shadman, MD, MPH^1,2, Chaitra S Ujjani, MD^1,2, Ryan C Lynch, MD^1,2, Brian G Till^1,2, Stephen D Smith, MD^1,2, David G Maloney, MD, PhD^1,2 and Ajay K Gopal, MD^1,2

¹Fred Hutchinson Cancer Center, Seattle, WA
²Division of Hematology and Oncology, University of Washington, Seattle, WA
³Division of Dermatology, University of Washington, Seattle, WA

Xiaomei Yang^1*, Jing Yang^2*, Shuang Huang^2*, Yanlong Duan^2*, Ling Jin^2*, Fu Li^1*, Lian Du^1*, Mincui Zheng^3*, Pan Wu^3*, Ying Liu^4*, Bo Hu^4*, Yunpeng Dai^5*, Guotao Guan^5*, Ansheng Liu^6*, Shuang Qin^6*, Lirong Sun^7*, Jian Jiang^8*, Wei Liu, MD^9*, Jianwen Zhou^9*, Jian Wang^10*, Lijun Qu^10*, Leping Zhang^11*, Yueping Jia^11*, Xiaojun Yuan^12*, Yushuang Dong^12*, Baoxi Zhang^13*, Lian Jiang^14*, ZhuJun Wang^15*, XiGe Wang^16*, Shuquan Zhuang^17*, Chunju Zhou^18*, Zifen Gao^19* and Yonghong Zhang^4*

¹Department of Pediatric Hematology/Oncology, Shandong University Affiliated Hospital (Jinan Children's Hospital), Jinan, China
²Department of Pediatric Oncology, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China
³Department of Hematology, Hunan Children's Hospital, Changsha, China
⁴Department of Pediatric Lymphoma, Beijing Gobroad Boren Hospital, Beijing, China
⁵Department of Pediatrics Hematology and Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
⁶Department of Hematologic Oncology, Xi'an Children's Hospital, Xi'an, China
⁷Department of Pediatric Hematology and Oncology, Affiliated Hospital of Qingdao University, Qingdao, China
⁸Department of Pediatric Hematology and Oncology ，Affiliated Hospital of Qingdao University, Qingdao, China
⁹Department of Hematology & Oncology, Zhengzhou Children's Hospital, Zhengzhou, China
¹⁰Department of Hematology and Oncology, Anhui Provincial Children’s Hospital, Hefei, China
¹¹Department of Pediatrics, Peking University People's Hospital, Beijing, China
¹²Department of Pediatric Hematology and Oncology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
¹³Department of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China
¹⁴Department of Pediatrics, The fourth Hospital of Hebei Medical University, Shijiazhuang, China
¹⁵Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹⁶Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
¹⁷Department of Pediatric,Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
¹⁸Department of Pathology, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China
¹⁹Department of Pathology, Peking University Third Hospital, Beijing, Beijing, China

Paul J Bröckelmann, MD^1*, Ina Bühnen^2*, Peter Herhaus, MD^3*, Julia Meissner, MD^4*, Karolin Trautmann-Grill, MD^5*, Horst Müller, PhD^1*, Michael Fuchs, MD^6*, Bastian von Tresckow, MD⁷, Peter Borchmann⁸, Andreas Engert, MD^1* and Karolin Behringer, MD^1*

¹Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
²Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany
³Clinic and Policlinic for Internal Medicine III, Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Munich, Germany
⁴Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
⁵Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Germany
⁶Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
⁷Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, Essen, Germany
⁸Department I of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Koeln, Germany

Héctor Alejandro Vaquera Alfaro, MD^1,2, Zulia Guzman-Martínez, MD^1,2*, Antonio Vega-Mateos, MD^1*, Yadith Karina Lopez-Garcia, MD^3*, Ana Cristina Tejada Vasquez^4*, Gerardo Garcia-Salas, MD¹, César Homero Gutierrez-Aguirre, PhD^1*, Olga Cantu, MD^1*, David Gomez-Almaguer, MD¹ and Perla R. Colunga-Pedraza, MD¹

¹Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
²Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
³Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico
⁴Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, GUATEMALA, Guatemala

Pravash Budhathoki^1*, Anish Shah^2*, Ujjwal Karki, MBBS³, Niraj Neupane, MD^4*, Sabita Shah, MD^5* and Karthickrajkumar Kariamanickam, MD^2*

¹Bronxcare Health System, BRONX, NY
²Bronxcare Health System, Bronx, NY
³Corewell Health William Beaumont University Hospital, Royal Oak
⁴Rochester General Hospital, Rochester, NY
⁵KIST Medical College, Kathmandu, Nepal

Fjoralba Kristo^1*, Victoria Federico Paly, MHS^1*, Katherine Fazioli, BS, MS^2*, Conor McCloskey, PhD^2*, Sunita Nair, PhD^2*, Bipin N. Savani, MD¹, Athanasios Zomas, MD^1* and Ajibade Ashaye, MD, MBA, MPH, MSc¹

¹Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
²Clarivate Analytics Ltd, London, United Kingdom

Alexandra Elias¹, Mario L. Marques-Piubelli, MD², Ranjit Nair, MD³, Rishab Prakash, BS^4*, Sairah Ahmed, MD⁴, Luis Malpica, MD^5*, Hun Ju Lee, MD^4*, Jie Xu, MD PhD^6*, Christopher R. Flowers, MD, MS⁴, Sattva S. Neelapu, MD⁴, Francisco Vega, MD, PhD⁷, Roberto Miranda, MD^8* and Swami P. Iyer, MD⁵

¹McGovern Medical School, Houston, TX
²Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Celine M. Schreidah^1*, David M. DeStephano, MPH^2*, Samuel S. Pan, MSc^2*, Shikun Wang, PhD^2*, Haoyang Shen, MS^3*, Casey N. Ta, PhD^4*, George Bingham Reynolds, MS^3*, Lauren M. Fahmy, BS¹, Emily R. Gordon, BA^1*, Oluwaseyi Adeuyan, BS^1*, Bradley D. Kwinta, MD^1*, Connor J. Stonesifer, MD^5*, Warren H. Chan, MD, MS^6*, Jaehyuk Choi, MD, PhD⁷, Madeleine Duvic, MD^8*, Fernando Gallardo, MD, PhD^9*, Michael Girardi, MD^10*, Joan Guitart, MD^7*, Youn H. Kim, MD¹¹, Michael S. Khodadoust, MD^11*, Safa Najidh, MD^12*, Xiao Ni, MD, PhD^8*, Ramon M. Pujol, MD, PhD^9*, Cornelis P. Tensen, PhD^12*, Maarten H. Vermeer, MD, PhD^12*, Sean Whittaker, MD^13*, Nicholas P. Tatonetti, PhD^3,4,14*, Herbert S. Chase, MD, MA^4*, Itsik Pe'er, PhD^3,15,16* and Larisa J. Geskin, MD^2,17*

¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY
²Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
³The Data Science Institute, Columbia University, New York, NY
⁴Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY
⁵Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL
⁶Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY
⁷Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL
⁸MD Anderson Cancer Center, The University of Texas, Houston, TX
⁹Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
¹⁰Department of Dermatology, Yale School of Medicine, New Haven, CT
¹¹Departments of Dermatology and Medicine - Oncology, Stanford University School of Medicine, Stanford, CA
¹²Department of Dermatology, Leiden University Medical Centre, Leiden, Netherlands
¹³St John's Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London, GBR
¹⁴Department of Computational Biomedicine and Cedars-Sinai Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA
¹⁵Department of Computer Science, Columbia University, New York, NY
¹⁶Department of Systems Biology, Columbia University, New York, NY
¹⁷Department of Dermatology, Columbia University Irving Medical Center, New York, NY

Hussien Ahmed H. Abdelgawad, MD, MS^1,2*, Mohamed Mohamed Belal^3*, Mohamed Nabih Bashir^3*, Heba Aboeldahab, MD^4,5*, Francis Eshun, MD^1,2*, Mario Otto, MD, PhD^1,2 and Michael Henry, MD^1,2*

¹Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ
²Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ
³Faculty of Medicine, Alexandria University, Alexandria, Egypt
⁴Clinical Research Department, El-Gomhoria General Hospital, Alexandria, Egypt
⁵Biomedical Informatics and Medical Statistics Department, Medical Research Institute, Alexandria University, Alexandria, Egypt

Herve Ghesquieres, MD^1*, Krimo Bouabdallah, MD^2*, Marc Andre, MD, PhD^3*, Philippe Quittet, MD^4*, Cecile Borel, MD^5*, Aspasia Stamatoulas Bastard, MD^6*, Michael Gilbertson, MD^7*, Fabien Le Bras, MD^8*, Catherine Thieblemont, MD^9*, Baptiste Delapierre, MD^10*, Mohamed Touati^11*, Pierre Feugier, MD, PhD^12*, Julien Lazarovici, MD^13*, Nadine Morineau, MD^14*, Thomas Gastinne, MD^15*, Isabelle Chaillol^16*, Rod Ramchandren, MD¹⁷, Harsh Shah, DO¹⁸, Dipenkumar Modi, MD¹⁹, Heather Allewelt, MD^20*, Pierre Fustier, MD^21*, Jianfeng Xu^22*, Amit Agarwal^22*, Franck Morschhauser, phd²³ and Cedric Rossi, MD, PhD^24*

¹Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
²CHU Bordeaux Pessac, Bordeaux, FRA
³CHU UCL Namur, Yvoir, Belgium
⁴CHU Montpellier, Montpellier, France
⁵IUCT Oncopole, Toulouse, France
⁶Centre Henri Becquerel, Rouen, FRA
⁷Monash Health, Melbourne, Australia
⁸Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
⁹Hopital Saint-Louis, Paris, France
¹⁰Caen University Hospital, Caen, FRA
¹¹Hématologie Clinique et Hospitalisation à domicile, CHU Limoges, LIMOGES CEDEX 1, France
¹²CHU Nancy, Nancy, FRA
¹³Gustave Roussy Institute, Villejuif, FRA
¹⁴CHD de Vendee, La Roche Sur Yon, France
¹⁵CHU de Nantes, Nantes, France
¹⁶Lymphoma Academic Research Organisation, Lyon, France
¹⁷University of Tennessee Medical Center, Knoxville, TN
¹⁸Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁹Barbara Ann Karmanos Cancer Institute, Detroit, MI
²⁰BeiGene USA, Inc, San Mateo, CA
²¹BeiGene, Basel, Switzerland
²²BeiGene, San Mateo, CA
²³CHU de Lille, Lille, France
²⁴CHU Dijon, Dijon, France